NovoCure Limited Ordinary Shares
S$23.27
SGD
Last updated on --.
24h volume1.93M
24h highest23.8491 SGD
24h lowest22.7377 SGD
24h Price movement+1.45%
NVCR recent prices
24 Hours
+1.45%+S$0.33212
30 days
+43.83%+S$6.987
60 days
+63.63%+S$8.916
90 days
+19.75%+S$3.781
Key data
Previous close22.9421 SGD
Market cap2.63B SGD
Volume1.93M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.9033 SGD
Net income (FY)-221.05M SGD
Revenue (FY)861.50M SGD
Last report dateApr 30, 2026
About NovoCure Limited Ordinary Shares
HeadquartersST. HELIER
Employees (FY)1.61K
Revenue per employee (FY)536.76K SGD
Net income per employee (FY)-137.73K SGD
Listed onNasdaq
NVCR conversion tables
 |  |
|---|---|
| 0.5 NVCR | 11.63 SGD |
| 1 NVCR | 23.27 SGD |
| 5 NVCR | 116.37 SGD |
| 10 NVCR | 232.74 SGD |
| |
|---|---|
| 0.5 SGD | 0.021483 NVCR |
| 1 SGD | 0.042966 NVCR |
| 5 SGD | 0.21483 NVCR |
| 10 SGD | 0.42966 NVCR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NVCR is trading at S$23.27, +1.45% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NVCR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NVCR is currently trading at S$23.27, +1.45% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NVCR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NVCR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NVCR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NVCR's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
NovoCure Limited Ordinary Shares's market cap is currently 2.63B SGD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.93M
24h highest23.8491 SGD
24h lowest22.7377 SGD
24h Price movement+1.45%
Start trade with NVCR Perpetual
Sign up to trade